To update state-specific estimates of diabetes-attributable costs in the U.S. and assess changes in spending from 2013 to 2021.
No takes yet. Share an insight, caveat, or question.
Khavjou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: